Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging advanced algorithms to expedite drug discovery and development. This ...

UiPath (PATH) announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by ...

Cathie Wood’s ARK ETFs have made significant moves in their daily trading activity for Tuesday, April 8th, 2025, with NVIDIA Corp (NASDAQ: NVDA) and UiPath Inc (NYSE: PATH) standing out among the ...